Nomogram development and evaluation for resectable colorectal cancer based on preoperative hemoglobin levels and lymphocyte to monocyte ratio:a retrospective cohort study

Author:

Zhou Jie1,Tian Mengjie1,Zhang Xiangchen1,Xiong Lingyi1,Xu Hongli1,Yin Zhucheng1,Wu Fengyang1,Hu Junjie1,Liang Xinjun1,Wei Shaozhong1

Affiliation:

1. Hubei Cancer Hospital, Huazhong University of Science and Technology

Abstract

Abstract Background: The impact of lymphocyte to monocyte ratio (LMR) and hemoglobin (Hb) level on the prognosis of solid tumors and hematological malignancies was reported. Therefore, we sought to investigate the prognostic value of LMR-Hb based biomarker in resectable colorectal cancer (CRC). Methods: Clinical data from 700 CRC patients received radical surgery at Hubei Cancer Hospital from 2013 to 2016 were retrospectively analyzed. To evaluate the connection between clinical outcomes and elements regarding demographics, pathological and laboratory index, we conducted Multivariate Cox regression. A novel nomogram was developed, and its performance was evaluated by its discrimination, calibration, and clinical usefulness. Results: Kaplan-Meier method demonstrated that poorer overall survival (OS) and disease-free survival (DFS) was associated with higher Hb-LMR Score (P < 0.0001). Multivariate Cox regression illustrated that age at surgery greater than or equal to 65 years, female, the rate of lymph nodes metastasis reaching 0.077 or more, invasion of circumferential resection margin, TNM staging in III-IV, and Hb-LMR score of 2 were independent risk factors for poor OS or DFS. The area under the time-dependent receiver operating characteristic curve, the calibration curve along with decision curve analysis were performed and revealed that the nomogram was excellent in discrimination, calibration and efficacy. The concordance index illustrated that the nomogram has more accurate predictive ability for OS and DFS than TNM stage alone. Conclusion: Based on preoperative Hb and LMR, we successfully developed a novel and easily accessible prognostic score which had a good performance in predicting clinical outcomes in CRC patients.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3